advertisement

Wednesday, July 9, 2008
Infectious Diseases
Shingles
AboutPreventionSymptomsTestsTreatmentManaging

Prevention

A shingles vaccine, Zostavax, was approved by the FDA in May of 2006 for use in adults 60 years of age or older. According to research published in the New England Journal of Medicine, the vaccine cut the occurrence of shingles in half and reduced the severity and complications in people who were vaccinated but still developed shingles. The vaccine is available by prescription. The vaccine is given as one shot under the skin.

Related Links
Bullet More information about shingles
Bullet Shingles-Related Clinical Trials Information
0
Email this sectionEmail this pagePrint this sectionPrint this section
0
0
0
Content last updated: 1/29/07Previous PagePrevious page Next Section: SymptomsNext Page




U.S. News's featured content providers were not involved in the selection of advertisers appearing on this website, and the placement of such advertisement in no way implies that these content providers endorse the products and services advertised. Disclaimer and a note about your health.

advertisement

advertisement

advertisement


Copyright © 2007 U.S.News & World Report, L.P. All rights reserved.

Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.